Delivery Order SPE2DB20D1100-SPE2DB25FB4X5
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award SPE2DB22D1106|SPE2DB25FDPM8 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.60 firm fixed price delivery order contract is for the supply of Azelastine 0.1% (137 MCG) Spray, 30 ML. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,333.44 firm-fixed-price delivery order is for the supply of AZELASTINE 0.1% (137 MCG) SPRY 30ML, a pharmaceutical product. The award has an ultimate completion date of August 10, 2022 and was issued on August 9, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.05 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB22FQ05A, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,237.04 delivery order contract is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product, with a completion date of September 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
The federal contract award SPE2DB20D2104|SPE2DB23FU64W was issued by the Defense Logistics Agency (DLA) to prime contractor Amerisourcebergen Drug Corp. The $1,236.67 firm fixed-price delivery order is for the supply of 4561655782 - AZELASTINE 0.1% (137 MCG) SPRY 30ML, with a performance period through August 1, 2023. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,523.57, is for the delivery of Azelastine 0.1% eye drops. The contract is a Firm Fixed Price Delivery Order with a completion date of June 26, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,380.72, is for the delivery of Azelastine 0.1% (137 MCG) Spry 30ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
This federal contract award, identified as SPE2DB20D2001|SPE2DB22FM44L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,660.44 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) nasal spray, a medication used for the treatment of nasal symptoms associated with allergies. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,175.32 Firm Fixed Price Delivery Order contract is for the supply of AZASITE 1% eye drops, 2.5ml, with a performance period through March 12, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award (SPE2DB20D2104|SPE2DB22FS22R) is for the delivery of Azelastine 0.1% (137 MCG) nasal spray, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.24 and a performance period ending on March 29, 2022. The contract was not set aside for any specific business...